• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Hospira Inc.

Miles White’s fearless strategy for growing Abbott

January 10, 2020 By Nancy Crotti

With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone unturned as he grew Abbott into one of the world’s largest medical device companies. Few medical device companies have seen the growth and transformation that Abbott (NYSE:ABT) has seen under the leadership of Miles White. During his two decades as […]

Filed Under: Business/Financial News, Cardiovascular, Diabetes, Diagnostics, Featured, Implants, Neuromodulation/Neurostimulation, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Abbott, AbbVie, Guidant Corp., Hospira Inc., stjudemedical

In midst of Epipen shortage, Kaleo confirms ‘sufficient supply’ of Auvi-Q auto-injectors

August 14, 2018 By Sarah Faulkner

Kaleo said today that despite ongoing manufacturing delays reported by epinephrine auto-injector manufacturers, Kaleo’s Auvi-Q device is available via prescription and that the privately-held company has ‘sufficient supply to meet any anticipated demand.’ Kaleo’s epinephrine auto-injector features voice instructions that guide users through the drug-delivery process and an auto-retractable needle system, according to the company. Get […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Respiratory Tagged With: Hospira Inc., Impax Laboratories, Kaleo Inc, Mylan

Hospira issues nationwide recall for opioid overdose reversal drug

June 6, 2018 By Sarah Faulkner

Pfizer’s Hospira unit this week voluntarily recalled two lots of a drug used to reverse the course of an opioid overdose. The company’s naxolone injection, sold in its Carpuject single-use cartridge syringe, was recalled due to the potential presence of embedded and loose particulate matter in the plunger. Get the full story at our sister site, Drug Delivery […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Recalls, Wall Street Beat Tagged With: Hospira Inc., Pfizer

ICU Medical touts dosing errors study

February 15, 2017 By Sarah Faulkner

ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira (NYSE:HSP) MedNet safety software were integrated with the hospitals’ electronic medical records. The rate of potentially catastrophic dosing errors fell by 52% after smart-pump EMR integration, the study found, […]

Filed Under: Hospital Care, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: Hospira Inc., ICU Medical Inc., Pfizer

ICU Medical closes $900m buyout of Pfizer’s Hospira infusion pump biz

February 8, 2017 By Brad Perriello

ICU Medical (NSDQ:ICUI) this week closed its $900 million acquisition of the Hospira infusion pump business from Pfizer (NYSE:PFE), confirming last year’s rumors that the drug giant was looking to sell the business. The deal, which was scaled back from $1 billion last month, called for ICU Medical to offer 3.2 million new shares, or $419.3 million, and $275 million in cash, […]

Filed Under: Hospital Care, Mergers & Acquisitions, Wall Street Beat Tagged With: Hospira Inc., ICU Medical Inc., Pfizer

Pfizer agrees to $100m haircut in Hospira infusion sale to ICU Medical

January 6, 2017 By Fink Densford

Pfizer (NYSE:PFE) has agreed to take a $100 million hit on its previously $1 billion sale of its Hospira infusion pump business to ICU Medical (NSDQ:ICUI), bringing in approximately $900 million. The revised deal calls for ICU Medical to offer 3.2 million new shares, or $419.3 million, and $275 million in cash, along with an additional possible […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Hospira Inc., ICU Medical Inc., Pfizer

Pfizer’s Hospira, Iatric Systems ink infusion pump interoperability deal

December 19, 2016 By Fink Densford

Pfizer (NYSE:PFE) said today that its Hospira subsidiary and healthcare IT group Iatric Systems inked a partnership deal to develop interoperability between Hospira’s smart infusion pumps and Iatric’s Accelero Connect integration software. The 2 companies said they are currently piloting smart-pump EMR interoperability at an undisclosed US hospital. “Hospira is proud to partner with Iatric […]

Filed Under: Business/Financial News, Drug Pumps, Software / IT Tagged With: Hospira Inc., Iatric Systems

ICU Medical to pay Pfizer $1B for Hospira infusion pump biz

October 6, 2016 By Brad Perriello

ICU Medical (NSDQ:ICUI) agreed to pay $1 billion in cash and stock for the Hospira infusion pump business owned by Pfizer (NYSE:PFE), confirming rumors that swirled earlier this year that the drug giant was looking to sell the business. The deal calls for ICU Medical to put up $400 million worth of new shares and $600 million in […]

Filed Under: Drug Pumps, Mergers & Acquisitions, Wall Street Beat Tagged With: Hospira Inc., ICU Medical Inc., Pfizer

Fresenius, Smiths in the hunt for Pfizer’s $1.5B infusion pump biz

June 7, 2016 By Varun Saxena

Germany’s Fresenius (NYSE:FMS) and Britain’s Smiths Group (LON:SMIN) have emerged as the final bidders for Pfizer‘s (NYSE:PFE) infusion pump business, inherited via the Big Pharma’s September 2015 purchase of Hospira for $15 billion. The winning bid is expected to be around $1.5 billion, according to Reuters. Private equity firm Pamplona Capital Management was also interested and reportedly made a […]

Filed Under: Drug Pumps, Drug-Device Combinations, Mergers & Acquisitions, Wall Street Beat Tagged With: Fresenius, Hospira Inc., Pfizer, Smiths Group plc

Hospira launches new LifeCare PCA EMR-linked infusion pump

May 20, 2016 By Fink Densford

Hospira said yesterday it is launching the LifeCare PCA 7.0 patient-controlled analgesia infusion pump designed for patient pain management. The company is touting the device as the 1st-PCA infusion pump to offer electronic medical record integration through the use of inegrated bar code identification of prefilled of pharmacy-filled drug vials. “Hospira is proud to deliver the […]

Filed Under: Business/Financial News, Drug Pumps Tagged With: Hospira Inc.

Novartis taps Hospira-sale engineer exec Ball to revive slumping Alcon

January 27, 2016 By Fink Densford

Novartis (NYSE:NVS) is looking to revitalize its slumping Alcon eye care division by picking up medical vet Michael Ball, who recently organized Hospira’s $15 billion sale to Pfizer (NYSE:PFE). Ball will replace previous Alcon chief Jeff George, the company announced today. Novartis CEO Joe Jimenez is reportedly putting Ball in control of reviving Alcon. Alcon […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Alcon, Hospira Inc., Novartis, Pfizer

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy